steve_oldfield_emg

EMG appoints new chair and officers

pharmafile | April 4, 2014 | Appointment | Manufacturing and Production, Medical Communications, Research and Development, Sales and Marketing |  EMG, Sanofi, oldfield 

Sanofi UK and Ireland’s managing director Steve Oldfield has been elected as chair of the European Medicines Group (EMG). 

Oldfield (pictured) takes over from Lundbeck UK’s managing director Steve Turley, who held the post for the previous two years.  

Oldfield will be supported by new vice-chair David Garmon-Jones, general manager, Merck Serono UK and Ireland (who takes over from Actelion’s Robin Bhattacherjee) and re-elected Treasurer, Mike Sumpter, chief executive, Servier Laboratories.

 

Advertisement

Oldfield says: “Our members represent a significant proportion of the research-based industry operating in the UK. For all, regardless of our size or the areas in which we specialise, either trying to ensure or improving patient access to, or uptake of new medicines is the number one priority. Low and slow uptake of new medicines is systemic in the UK.
”

Related Content

Excellence in Healthcare Partnership Awards – A Collaborative Working Project Between Sanofi and The University Hospital Birmingham Severe Asthma Team

Launched in February 2026 by PMGroup Worldwide Ltd and Visions4Health, the Excellence in Healthcare Partnerships …

Sanofi and Regeneron’s Dupixent receives CHMP recommendation for chronic spontaneous urticaria

Sanofi and Regeneron have received a positive opinion from the European Medicines Agency’s (EMA) Committee …

Sanofi’s treatment granted orphan designation for rare chronic inflammatory condition

The European Medicines Agency has granted orphan designation to Sanofi’s investigational Bruton’s tyrosine kinase (BTK) …

The Gateway to Local Adoption Series

Latest content